CureVac N.V. (ETR:5CV)
3.138
-0.062 (-1.94%)
Feb 21, 2025, 5:35 PM CET
CureVac Employees
As of December 31, 2023, CureVac had 1,172 total employees, including 999 full-time and 173 part-time employees. The number of employees increased by 123 or 11.73% compared to the previous year.
Employees
1,172
Change (1Y)
123
Growth (1Y)
11.73%
Revenue / Employee
€60,644
Profits / Employee
€256,381
Market Cap
708.26M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,172 | 123 | 11.73% |
Dec 31, 2022 | 1,049 | 165 | 18.67% |
Dec 31, 2021 | 884 | 330 | 59.57% |
Dec 31, 2020 | 554 | 100 | 22.03% |
Dec 31, 2019 | 454 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 62,908 |
Bayer Aktiengesellschaft | 96,931 |
Fresenius SE & Co. KGaA | 193,865 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 119,845 |
Carl Zeiss Meditec AG | 5,730 |
SCHOTT Pharma AG & Co. KGaA | 4,690 |
CureVac News
- 4 days ago - CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators - Wallstreet:Online
- 4 days ago - CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World's Top Innovators - Accesswire
- 4 days ago - CureVac: LexisNexis Names It a Global Innovation Leader Again! - Wallstreet:Online
- 4 days ago - EQS-News: CureVac Earns Repeat Recognition by LexisNexis as One of the World’s Top Innovators - Wallstreet:Online
- 6 weeks ago - Why CureVac (CVAC) Shares Are Volatile - Benzinga
- 6 weeks ago - CureVac: Latest GBM Data Bodes Well For Next Program Check Point - Seeking Alpha
- 6 weeks ago - Why CureVac (CVAC) Stock Is Moving - Benzinga
- 6 weeks ago - Vaccine makers’ shares jump after bird flu death in US - Financial Times